Haima Therapeutics

Haima Therapeutics

Biotechnology Cleveland, Ohio, United States 14 employees
Employees
14
Contacts
4
Emails
4
Phones
2

Haima Therapeutics Overview

Headquarters
Cleveland, Ohio, United States
Industry
Biotechnology
Employees
14
Founded
2016
Funding
949.2K
Company Email
Available in AeroLeads

About Haima Therapeutics

Haima Therapeutics is a pre-clinical stage biotechnology company focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related ailments. We have developed a novel, nanoparticle-based synthetic hemostatic technology, called SynthoPlate, that can staunch hemorrhagic bleeding by binding to the site of injury and amplifying your body’s natural clotting mechanisms. Haima Therapeutics and Case Western Reserve University entered into an option to license agreement in April of 2018. Haima Therapeutics is located at the BioEnterprise incubator centrally located in the University Circle area near Case Western Reserve University, University Hospitals, and the Cleveland Clinic.

Haima Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Haima Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Kris Vulgan Managing Gp Ferocity Capital
Email
Stephen Flaim, Ph.d., Facc, Faha
Email Phone
Michael Bruckman CEO at Haima Therapeutics
Email Phone
Anirban Sen Gupta Wallace R. Persons Endowed Professor
Email

Employees by Management Level

Individual contributor 8 profiles
Executive 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 1

Haima Therapeutics Tech Stack

Data / AI 5 profiles

Compare Similar Companies to Haima Therapeutics